Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Maria Gonzalez-Angulo

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2009
A systems approach to analysis of molecular complexity in breast cancerBryan T Hennessy, Ana Maria Gonzalez-Angulo, Mark S Carey, et al.
Journal of Cancer|June 18, 2016
Effects of CDK4/6 Inhibition in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Cells with Acquired Resistance to PaclitaxelAdriana Priscila Trapé, Shuying Liu, Andrea Carolina Cortes, et al.
AJR. American Journal of Roentgenology|March 24, 2010
Multimodality imaging of triple receptor-negative tumors with mammography, ultrasound, and MRIBasak E Dogan, Ana Maria Gonzalez-Angulo, Michael Gilcrease, et al.
Clinical Breast Cancer|March 17, 2004
Paclitaxel improves the prognosis in estrogen receptor negative inflammatory breast cancer: the M. D. Anderson Cancer Center experienceMassimo Cristofanilli, Ana Maria Gonzalez-Angulo, Aman U Buzdar, et al.
Clinical Breast Cancer|July 2, 2013
Mesothelin expression and survival outcomes in triple receptor negative breast cancerNapa Parinyanitikul, George R Blumenschein, Yun Wu, et al.
Clinical Breast Cancer|January 24, 2007
Biologic markers in axillary node-negative breast cancer: differential expression in invasive ductal carcinoma versus invasive lobular carcinomaAna Maria Gonzalez-Angulo, Aysegul Sahin, Savitry Krishnamurthy, et al.
Clinical Breast Cancer|November 10, 2006
Downregulation of the cyclin-dependent kinase inhibitor p27kip1 might correlate with poor disease-free and overall survival in inflammatory breast cancerAna Maria Gonzalez-Angulo, Valentina Guarneri, Yun Gong, et al.
Cancer|April 22, 2011
Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: a large population-based studyShaheenah Dawood, Naoto T Ueno, Vicente Valero, et al.
The Breast Journal|May 28, 2014
Breast cancer subtype and baseline characteristics from diabetic breast cancer patients are not different from nondiabeticsSaúl Campos-Gomez, Vicente Valero, Jose Humberto Flores-Arredondo, et al.
The Breast Journal|November 7, 2007
Adjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free survival of malignant phyllodes tumors of the breastFlavia Morales-Vásquez, Ana Maria Gonzalez-Angulo, Kristine Broglio, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2009
A systems approach to analysis of molecular complexity in breast cancerBryan T Hennessy, Ana Maria Gonzalez-Angulo, Mark S Carey, et al.
Journal of Cancer|June 18, 2016
Effects of CDK4/6 Inhibition in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Cells with Acquired Resistance to PaclitaxelAdriana Priscila Trapé, Shuying Liu, Andrea Carolina Cortes, et al.
AJR. American Journal of Roentgenology|March 24, 2010
Multimodality imaging of triple receptor-negative tumors with mammography, ultrasound, and MRIBasak E Dogan, Ana Maria Gonzalez-Angulo, Michael Gilcrease, et al.
Clinical Breast Cancer|March 17, 2004
Paclitaxel improves the prognosis in estrogen receptor negative inflammatory breast cancer: the M. D. Anderson Cancer Center experienceMassimo Cristofanilli, Ana Maria Gonzalez-Angulo, Aman U Buzdar, et al.
Clinical Breast Cancer|July 2, 2013
Mesothelin expression and survival outcomes in triple receptor negative breast cancerNapa Parinyanitikul, George R Blumenschein, Yun Wu, et al.
Clinical Breast Cancer|January 24, 2007
Biologic markers in axillary node-negative breast cancer: differential expression in invasive ductal carcinoma versus invasive lobular carcinomaAna Maria Gonzalez-Angulo, Aysegul Sahin, Savitry Krishnamurthy, et al.
Clinical Breast Cancer|November 10, 2006
Downregulation of the cyclin-dependent kinase inhibitor p27kip1 might correlate with poor disease-free and overall survival in inflammatory breast cancerAna Maria Gonzalez-Angulo, Valentina Guarneri, Yun Gong, et al.
Cancer|April 22, 2011
Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: a large population-based studyShaheenah Dawood, Naoto T Ueno, Vicente Valero, et al.
The Breast Journal|May 28, 2014
Breast cancer subtype and baseline characteristics from diabetic breast cancer patients are not different from nondiabeticsSaúl Campos-Gomez, Vicente Valero, Jose Humberto Flores-Arredondo, et al.
The Breast Journal|November 7, 2007
Adjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free survival of malignant phyllodes tumors of the breastFlavia Morales-Vásquez, Ana Maria Gonzalez-Angulo, Kristine Broglio, et al.
Pageof 8